Piceatannol-3′-O-β-d-glucopyranoside mitigates myocardial ischemia-reperfusion injury by inhibiting ferroptosis through the regulation of NDUFS1 lactylation via metabolic reprogramming

Myocardial ischemia-reperfusion injury (MIRI) is a key factor affecting the prognosis of myocardial infarction patients. Currently, there remains a lack of specific drugs targeting MIRI, and it is unclear whether Piceatannol-3′-O-β-d-glucopyranoside (PG) improves MIRI through metabolic reprogramming...

Descripció completa

Dades bibliogràfiques

Autors principals:	Genhao Fan, Chidao Zhang, Wenqing Zhang, Xuli Ji, Menglin Liu, Peng Chen, Boyong Qiu, Yankun Song, Min Zhang, Teng Ma, Zhengwei Dong, Zuoying Xing, Yuhong Huang, Mingjun Zhu, Yongxia Wang
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2026-07-01
Col·lecció:	Redox Biology
Matèries:	Piceatannol-3′-O-β-d-glucopyranoside Lactylation MIRI Ferroptosis Metabolic reprogramming
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2213231726001965
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!